1. Market Research
  2. > Pharmaceutical
  3. > OTC Market Trends
  4. > OTC Pharmaceuticals in Italy

OTC Pharmaceuticals in Italy

  • September 2016
  • -
  • MarketLine
  • -
  • 39 pages

Summary
OTC Pharmaceuticals in Italy industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2011-15, and forecast to 2020). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Key Findings
Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the otc pharmaceuticals market in Italy

Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the otc pharmaceuticals market in Italy

Leading company profiles reveal details of key otc pharmaceuticals market players' global operations and financial performance

Add weight to presentations and pitches by understanding the future growth prospects of the Italy otc pharmaceuticals market with five year forecasts

Synopsis
Essential resource for top-line data and analysis covering the Italy otc pharmaceuticals market. Includes market size and segmentation data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.

Reasons To Buy
What was the size of the Italy otc pharmaceuticals market by value in 2015?

What will be the size of the Italy otc pharmaceuticals market in 2020?

What factors are affecting the strength of competition in the Italy otc pharmaceuticals market?

How has the market performed over the last five years?

Who are the top competitors in Italy's otc pharmaceuticals market?

Key Highlights
The OTC pharmaceuticals market consists of the retail sale of traditional medicines, cough and cold preparations (tablets, mixtures, lozenges, topical remedies, inhalers), vitamins and minerals (multi-vitamins, single minerals, single vitamins, tonics, cod liver oil), indigestion preparations (tablets, powders, mixtures), analgesics (Paracetamol, Ibuprofen, Aspirin and other analgesics), medicated skin products (anti-bacterials, acne treatments, anti-fungal, disinfectants and other), topical OTC medicines (anesthetic products, anti-itch products, antibiotic creams/gels), plasters and bandages (adhesive bandages/plasters, first aid tape, gauze pads/rolled gauze, liquid bandages and other tape or bandage), first aid kits and other (anti-smoking aids, rectal medications, eye/ear drops, sleeping aids, and motion sickness). The market is valued according to retail selling price (RSP) and includes any applicable taxes. Any currency conversions used in the creation of this report have been calculated using constant 2015 annual average exchange rates.

The Italian OTC Pharmaceuticals market generated total revenues of $3,265.3m in 2015, representing a CAGR of 2.0% between 2011 and 2015.

Cough and cold preparations registered the highest sales value in the Italian OTC Pharmaceuticals market in 2015, with total sales of $876.7m, equivalent to 26.8% of the market's overall value.

According to the OECD, Italy spent an estimated 9.1% of its GDP on healthcare in 2015.

Table Of Contents

OTC Pharmaceuticals in Italy
Table of Contents
Executive Summary
Market value
Market value forecast
Category segmentation
Geography segmentation
Market share
Market rivalry
Market Overview
Market definition
Market analysis
Market Data
Market value
Market Segmentation
Category segmentation
Geography segmentation
Market share
Market distribution
Market Outlook
Market value forecast
Five Forces Analysis
Summary
Buyer power
Supplier power
New entrants
Threat of substitutes
Degree of rivalry
Leading Companies
Bayer AG
Boehringer Ingelheim GmbH
Novartis AG
The Procter and Gamble Company
Macroeconomic Indicators
Country data
Methodology
Industry associations
Related MarketLine research
Appendix
About MarketLine

List of Tables
Table 1: Italy OTC pharmaceuticals market value: $ million, 2011-15
Table 2: Italy OTC pharmaceuticals market category segmentation: $ million, 2015
Table 3: Italy OTC pharmaceuticals market geography segmentation: $ million, 2015
Table 4: Italy OTC pharmaceuticals market share: % share, by value, 2015
Table 5: Italy OTC pharmaceuticals market distribution: % share, by value, 2015
Table 6: Italy OTC pharmaceuticals market value forecast: $ million, 2015-20
Table 7: Bayer AG: key facts
Table 8: Bayer AG: key financials ($)
Table 9: Bayer AG: key financials (€)
Table 10: Bayer AG: key financial ratios
Table 11: Boehringer Ingelheim GmbH: key facts
Table 12: Boehringer Ingelheim GmbH: key financials ($)
Table 13: Boehringer Ingelheim GmbH: key financials (€)
Table 14: Boehringer Ingelheim GmbH: key financial ratios
Table 15: Novartis AG: key facts
Table 16: Novartis AG: key financials ($)
Table 17: Novartis AG: key financial ratios
Table 18: The Procter and Gamble Company: key facts
Table 19: The Procter and Gamble Company: key financials ($)
Table 20: The Procter and Gamble Company: key financial ratios
Table 21: Italy size of population (million), 2011-15
Table 22: Italy gdp (constant 2005 prices, $ billion), 2011-15
Table 23: Italy gdp (current prices, $ billion), 2011-15
Table 24: Italy inflation, 2011-15
Table 25: Italy consumer price index (absolute), 2011-15
Table 26: Italy exchange rate, 2011-15

List of Figures
Figure 1: Italy OTC pharmaceuticals market value: $ million, 2011-15
Figure 2: Italy OTC pharmaceuticals market category segmentation: % share, by value, 2015
Figure 3: Italy OTC pharmaceuticals market geography segmentation: % share, by value, 2015
Figure 4: Italy OTC pharmaceuticals market share: % share, by value, 2015
Figure 5: Italy OTC pharmaceuticals market distribution: % share, by value, 2015
Figure 6: Italy OTC pharmaceuticals market value forecast: $ million, 2015-20
Figure 7: Forces driving competition in the OTC pharmaceuticals market in Italy, 2015
Figure 8: Drivers of buyer power in the OTC pharmaceuticals market in Italy, 2015
Figure 9: Drivers of supplier power in the OTC pharmaceuticals market in Italy, 2015
Figure 10: Factors influencing the likelihood of new entrants in the OTC pharmaceuticals market in Italy, 2015
Figure 11: Factors influencing the threat of substitutes in the OTC pharmaceuticals market in Italy, 2015
Figure 12: Drivers of degree of rivalry in the OTC pharmaceuticals market in Italy, 2015
Figure 13: Bayer AG: revenues and profitability
Figure 14: Bayer AG: assets and liabilities
Figure 15: Boehringer Ingelheim GmbH: revenues and profitability
Figure 16: Boehringer Ingelheim GmbH: assets and liabilities
Figure 17: Novartis AG: revenues and profitability
Figure 18: Novartis AG: assets and liabilities
Figure 19: The Procter and Gamble Company: revenues and profitability
Figure 20: The Procter and Gamble Company: assets and liabilities

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
North America Vision Care Market Outlook to 2022

North America Vision Care Market Outlook to 2022

  • $ 5995
  • Industry report
  • December 2016
  • by Global Data

North America Vision Care Market Outlook to 2022 Summary GlobalData’s new report, "North America Vision Care Market Outlook to 2022", provides key market data on the North America Vision Care market. ...

Animal Antibiotics and Antimicrobials Market by Product, Mode of Delivery, Animal - Global Forecast to 2021

Animal Antibiotics and Antimicrobials Market by Product, Mode of Delivery, Animal - Global Forecast to 2021

  • $ 5650
  • Industry report
  • December 2016
  • by MarketsandMarkets

The global animal antibiotics and antimicrobials market is estimated to grow at a CAGR of 4.6% from 2016 to 2021, to reach USD 4.73 billion by 2021 from USD 3.77 billion in 2016. The growth of this market ...

U.S. Insomnia Market by Non-Pharmacological Therapy, Prescription Sleep Aids, Orexin Antagonist & OTC Treatment - Forecasts to 2021

U.S. Insomnia Market by Non-Pharmacological Therapy, Prescription Sleep Aids, Orexin Antagonist & OTC Treatment - Forecasts to 2021

  • $ 5650
  • Industry report
  • January 2017
  • by MarketsandMarkets

The U.S. insomnia market is projected to reach USD 4.24 billion by 2021 from USD 3.38 billion in 2016, growing at a CAGR of 4.6% from 2016 to 2021 In 2016, the cognitive behavioural therapy for insomnia ...

Otc Drugs Markets In China

January 2017 $ 4000

Download Unlimited Documents from Trusted Public Sources

Salicylic Acid Market in the US

  • February 2017
    11 pages
  • Salicylic Acid  

    Pain Relief  

  • United States  

View report >

OTC Industry in the Netherlands

  • January 2017
    215 pages
  • Asthma  

    Health Care Pro...  

    Vitamin  

  • Netherlands  

View report >

Gastrointestinal Drug Industry in the US - Forecast

  • January 2017
    4 pages
  • Gastrointestina...  

    Digestive Syste...  

    Hormone  

  • United States  

View report >

Related Market Segments :

Pharmaceutical

ref:plp2016

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.